Experts question the validity of the CAS decision on Semenya



[ad_1]

The ruling means Semenya will have to take medication to suppress her naturally high levels of testosterone if she wants to compete internationally.

Caster Semenya is competing to win women's 800 meters at the IAAF Diamond League "Weltklasse" athletics meeting at the Letzigrund stadium in Zurich on August 30, 2018. Photo: AFP.

JOHANNESBURG (Reuters) – Questions are being raised Thursday morning over what options Caster Semenya has after a ruling by the Court of Arbitration for Sport (CAS) in favor of the new IAAF testosterone regulations, .

The ruling means Semenya will have to take medication to suppress her naturally high levels of testosterone if she wants to compete internationally.

Shuaib Manjra, a sports medicine scientist, said he could quit, appeal the decision or do hormone therapy, as he explained the implications of reducing Semenya in testosterone levels.

"If you reduce to less than 5, what degree of disadvantage will you have? I mean, Ross Tucker did some modeling on this and he finds out that if Caster Semenya reduces testosterone to less than 5, it will probably also be a race in the 800 meters. "

Semenya said she will not give up her fight against the IAAF.

Meanwhile, the concerns of the Sports Arbitration Court over IAAF regulations regarding testosterone levels of female athletes should have been sufficient to disrupt its implementation.

The executive director of the Institute of Sports Science is outraged.

Phatokuhle Zondi of the institute said: "Concern concerns the maintenance of testosterone level, they relate to the lack of complete evidence about 1,500 meters and of course the side effects.

"But these are issues important enough, as that is how they are framed in your press release. For me, to say that we should have been interrupted and delayed in implementing this regulation, if at all. [sic].

(Edited by Leeto M Khoza)

[ad_2]

Source link